NCT00435578View on ClinicalTrials.gov

Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Carcinoma, Small Cell Lung
Interventions
DRUG

Glufosfamide

Trial Locations (3)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

48201

Karmanos Cancer Institute, Detroit

94904

California Cancer Center, Greenbrae

Sponsors
All Listed Sponsors
lead

Threshold Pharmaceuticals

INDUSTRY

NCT00435578 - Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma | Biotech Hunter | Biotech Hunter